CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 80.96% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

WW International Q3 revenue slightly beats estimates on clinical subscription growth

By Reuters News


Overview

  • Weight management program's Q3 revenue fell 11% yr/yr, slightly beating analyst expectations

  • Company posted positive net income after a loss in the prior-year quarter

  • Adjusted EBITDA rose 21% yr/yr, driven by expense discipline and lower marketing spend


Outlook

  • WW International narrows 2026 revenue guidance to $625 mln-$630 mln from $620 mln-$635 mln

  • Company raises lower end of 2026 adj EBITDA outlook to $110 mln-$115 mln from $105 mln-$115 mln

  • Company says it will focus on improving member experience and product offerings


Result Drivers

  • CLINICAL SUBSCRIPTION GROWTH - Co said 48% yr/yr growth in clinical subscription revenue contributed to results

  • CORE+ SUBSCRIBER INCREASE - 16% yr/yr growth in higher-value Core+ subscribers supported results

  • HIGHER ARPU - 14% yr/yr increase in monthly subscription revenue per average subscriber, driven by clinical and Core+ mix


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Slight Beat*

$153 mln

$152.35 mln (3 Analysts)

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the personal services peer group is "buy"

  • Wall Street's median 12-month price target for WW International Inc is $27.50, about 126.7% above its November 4 closing price of $12.13


Reuters Recommended Reads

  • Nov 5 - Tapestry Q1 revenue and adjusted EPS beat estimates, outlook raised

  • Nov 5 - Warby Parker Q3 revenue rises on higher active customer count

  • Nov 5 - Elf sees Q2 sales boost with marketing, Europe expansion


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.